podocin Search Results


nphs2  (Bioss)
94
Bioss nphs2
Nphs2, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Polyclonal+Antibody/pm41569692-319-25-26
Average 94 stars, based on 1 article reviews
nphs2 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

95
Proteintech anti podocin
Anti Podocin, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/NPHS2+Polyclonal+antibody/pmc12516177-32-2-19
Average 95 stars, based on 1 article reviews
anti podocin - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology antipodocin primary antibody
Antipodocin Primary Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Antibody/pm34408785-104-9-13
Average 93 stars, based on 1 article reviews
antipodocin primary antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Novus Biologicals jb51
KEY RESOURCES TABLE Primary and secondary antibodies
Jb51, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin%2FNPHS2+Antibody+(JB51-33)/pmc10027389-28-5-2
Average 93 stars, based on 1 article reviews
jb51 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Novus Biologicals podocin
Figure 8: Protein levels <t>of</t> <t>nephrin,</t> <t>podocin,</t> and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).
Podocin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin%2FNPHS2+Antibody/pm38149181-52-21-22
Average 92 stars, based on 1 article reviews
podocin - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Novus Biologicals rabbit monoclonal podocin nphs2 antibody
Figure 8: Protein levels <t>of</t> <t>nephrin,</t> <t>podocin,</t> and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).
Rabbit Monoclonal Podocin Nphs2 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin%2FNPHS2+Antibody+(2O10G3)/pm35480869-101-6-10
Average 90 stars, based on 1 article reviews
rabbit monoclonal podocin nphs2 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Novus Biologicals podocin nphs2 antibody jb51 33
Figure 8: Protein levels <t>of</t> <t>nephrin,</t> <t>podocin,</t> and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).
Podocin Nphs2 Antibody Jb51 33, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin%2FNPHS2+Antibody+(JB51-33)/pmc12984592-5-1-11
Average 94 stars, based on 1 article reviews
podocin nphs2 antibody jb51 33 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Bioss fitc conjugated antipodocin
Figure 8: Protein levels <t>of</t> <t>nephrin,</t> <t>podocin,</t> and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).
Fitc Conjugated Antipodocin, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Polyclonal+Antibody%2C+FITC+Conjugated/pm26419704-161-42-45
Average 93 stars, based on 1 article reviews
fitc conjugated antipodocin - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Bioss podocin
MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), <t>anti-podocin</t> or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which shows podocytes with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.
Podocin, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Polyclonal+Antibody%2C+ALEXA+FLUOR+647+Conjugated/pmc06063476-435-15-17
Average 90 stars, based on 1 article reviews
podocin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bioss anti mouse podocin
MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), <t>anti-podocin</t> or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which <t>shows</t> <t>podocytes</t> with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.
Anti Mouse Podocin, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Polyclonal+Antibody%2C+Biotin+Conjugated/pmc06063476-448-11-14
Average 90 stars, based on 1 article reviews
anti mouse podocin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Bioss anti mouse
MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), <t>anti-podocin</t> or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which <t>shows</t> <t>podocytes</t> with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.
Anti Mouse, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/Podocin+Polyclonal+Antibody%2C+PE+Conjugated/pm39384961-108-27-31
Average 93 stars, based on 1 article reviews
anti mouse - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology mouse podocin enzyme-linked immunosorbent assay (elisa) kits (mybiosource, mbs722280)
MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), <t>anti-podocin</t> or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which <t>shows</t> <t>podocytes</t> with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.
Mouse Podocin Enzyme Linked Immunosorbent Assay (Elisa) Kits (Mybiosource, Mbs722280), supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocin/mouse+podocin+enzyme+linked+immunosorbent+assay++elisa++kits++mybiosource++mbs722280+/pmc04796871-163-11-15
Average 90 stars, based on 1 article reviews
mouse podocin enzyme-linked immunosorbent assay (elisa) kits (mybiosource, mbs722280) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE Primary and secondary antibodies

Journal: Cell reports

Article Title: Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration

doi: 10.1016/j.celrep.2022.110473

Figure Lengend Snippet: KEY RESOURCES TABLE Primary and secondary antibodies

Article Snippet: Anti-Podocin , Novus Biologicals , JB51–33 , NBP2–75624.

Techniques:

Figure 8: Protein levels of nephrin, podocin, and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).

Journal: Evidence-based complementary and alternative medicine : eCAM

Article Title: Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy.

doi: 10.1155/2022/9921679

Figure Lengend Snippet: Figure 8: Protein levels of nephrin, podocin, and Angptl3 in different groups: (a) control (C); (b) model group (M); (c) traditional Chinese medicine (TCM) group (M + Z); (d) (M + S); and (e) (M + Z + S). ∗M vs. C group (P < 0.05); &M + Z or M + S vs. M group (P < 0.05); #M + Z + S vs. M group (P < 0.01).

Article Snippet: Adriamycin (D1515, 10mg) was purchased from Sigma; prednisone (5mg) was obtained from Sinepharm (H31020675, Shanghai, China); antibodies against nephrin (Novus, NBP1-30130), podocin (Novus, NBP226057), and angptl3 (RnD, AF136) were used.

Techniques: Control

MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), anti-podocin or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which shows podocytes with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.

Journal: The Journal of Clinical Investigation

Article Title: CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease

doi: 10.1172/JCI99507

Figure Lengend Snippet: MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), anti-podocin or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which shows podocytes with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.

Article Snippet: Isolated cells were stained for flow cytometry with antibodies against nephrin (bs-10233R-A488, Bioss Antibodies) and podocin (bs-6597R-A647, Bioss Antibodies).

Techniques: Injection, Enzyme-linked Immunosorbent Assay, Staining, Expressing, Immunofluorescence, Fluorescence

MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), anti-podocin or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which shows podocytes with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.

Journal: The Journal of Clinical Investigation

Article Title: CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease

doi: 10.1172/JCI99507

Figure Lengend Snippet: MRL.lpr mice were injected i.p. with free KN93 (10 μg/wk), anti-podocin or anti-nephrin antibody–coated KN93-loaded nlg (10 μg of KN93/week), or empty nlg at from 8 to 16 weeks of age (n = 5–7 mice in each group). (A) Urine albumin/creatinine (Alb/Cre) ratio. Urine samples were obtained biweekly, and albumin and creatinine levels were determined by ELISA. Error bars represent mean ± SEM. *P < 0.05, 2-way ANOVA with Bonferroni’s post test. (B and C) Representative images of glomeruli from 16-week- old MRL.lpr mice treated with anti-nephrin antibody–coated empty nlg or KN93-loaded nlg. PAS (B) and Masson’s trichrome staining (C) are shown. The arrows point to the crescent. Scale bars: 50 μm. (D) Mean histological scores in the kidneys of mice from the indicated treatment groups (n = 5 in each group). *P < 0.05; **P < 0.01, Student’s t test. (E and F) Electron microscopic images of a glomerulus from a mouse treated with anti-nephrin empty nlg (left) showing diffuse podocyte foot process (FP) effacement with slit diaphragm occlusion (arrows) and subepithelial dense deposits (asterisks) and a mouse treated with anti-nephrin KN93-loaded nlg (right), which shows podocytes with normal foot processes and slit diaphragms and no deposits in the basement membrane. Original magnification, ×8,000 (E); ×30,000 (F). Three glomeruli were evaluated in each of 3 mice in each experimental condition. (G) C3 and IgG deposition was significantly suppressed in the glomeruli of MRL.lpr mice treated with KN93 targeted to podocytes, as indicated. Kidney sections from MRL/MpJ (16 weeks of age) mice are shown as controls (n = 5 mice in each group). (H) Nephrin (green) and synaptopodin (red) expression detected by immunofluorescence. Scale bars: 50 μm. (I) The fluorescence intensity of nephrin and synaptopodin quantified in glomeruli from mice subjected to the indicated treatments. ****P < 0.0001, Student’s t test. (J) Nphs1, Nphs2, and Synpo expression in glomeruli from mice treated with anti-nephrin–coated empty or KN93-loaded nlg. Results were normalized to the expression of GAPDH (n = 5 in each group). ****P < 0.0001, Student’s t test.

Article Snippet: To achieve targeting ability for podocytes, nlg was incubated with biotin-conjugated anti-mouse podocin (bs-6597R-Biotin, Bioss Antibodies) or nephrin antibodies (bs-10233R-Biotin, Bioss Antibodies) for 20 minutes at room temperature before injection.

Techniques: Injection, Enzyme-linked Immunosorbent Assay, Staining, Expressing, Immunofluorescence, Fluorescence